Programing Cells in a Predictable and Scalable Way
The Bio Report - En podcast af Levine Media Group - Onsdage

Kategorier:
Mark Kotter, founder and CEO of Bit.Bio, discusses the company’s platform technology, its effort to develop cell therapies, and its growing offering of precision reprogramed human cells for drug development.